前列腺癌早期诊断的研究进展  

The progress in early diagnosis of prostate cancer

作　　者：邓姣 马金鹏 杨德林[1] DENG Jiao;MA Jinpeng;YANG Delin(Department of Urinary Surgery,the Second Affiliated Hospital of Kunming Medical University,Yunnan Kunming 650101)

机构地区：[1]昆明医科大学第二附属医院泌尿外科,云南昆明650101

出　　处：《现代肿瘤医学》2022年第5期903-907,共5页Journal of Modern Oncology

基　　金：国家自然科学基金地区项目(编号:81860453);昆明医科大学研究生创新基金(编号:20121S231)。

摘　　要：前列腺癌(prostate cancer, PCa)是中老年男性常见恶性肿瘤之一,目前尚缺乏有效的晚期癌症治疗方法,因此早期诊断对于降低PCa死亡率至关重要。近年来,较多研究开发出多种新型诊断方法以改善对PCa诊断的准确性,同时避免过度诊疗,但其有效性及实用性尚需进一步验证。本文对目前新型生物标志物、联合成像技术及风险预测模型等的早期诊断技术进行总结,以期为临床研究提供指导作用。Prostate cancer is one of the common malignant tumors in middle-aged and elderly men.There is no effective treatments for advanced cancer.Therefore, early diagnosis is essential to reduce the mortality of prostate cancer.In recent years, many research has developed new diagnostic methods to improve the accuracy of prostate cancer diagnosis, while avoiding over-diagnosis and over-treatment, its effectiveness and practicality need verification.This article summarizes the current early diagnosis technologies such as new biomarkers, combined imaging technology and risk prediction model, in order to provide guidance for clinical research.

关 键 词：前列腺癌 早期诊断 新型生物标志物 影像学技术 风险预测模型 

分 类 号：R737.25[医药卫生—肿瘤]